Effect of the Echinocandin Caspofungin on Expression of Candida albicans Secretory Aspartyl Proteinases and Phospholipase In Vitro
- 1 September 2002
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 46 (9) , 3096-100
- https://doi.org/10.1128/aac.46.9.3096-3100.2002
Abstract
Although the echinocandin caspofungin primarily inhibits the synthesis of cell wall 1,3-beta-D-glucan, its fungicidal activity could also potentially perturb the expression of virulence factors involved in the ability of Candida albicans to cause infection. Expression of the C. albicans secretory aspartyl proteinase (SAP) and phospholipase B (PLB) virulence genes was determined by reverse transcription-PCR after the addition of caspofungin to cells grown for 15 h in Sabouraud dextrose broth. In cells that remained viable, expression of SAP1 to SAP3, SAP7 to SAP9, and PLB1 was unaltered after exposure to fungicidal concentrations (4 to 16 micro g/ml) of caspofungin over a period of 7 h. However, expression of SAP5 increased steadily beginning 1 h after exposure to caspofungin. These results indicate that caspofungin is rapidly fungicidal against C. albicans, before any suppression of SAP or PLB1 gene expression can occur.Keywords
This publication has 57 references indexed in Scilit:
- Evidence for Differential Expression ofCandida albicansVirulence Genes during Oral Infection in Intact and Human Immunodeficiency Virus Type 1–Transgenic MiceThe Journal of Infectious Diseases, 2002
- Update on antifungals targeted to the cell wall: focus on β-1,3-glucan synthase inhibitorsExpert Opinion on Investigational Drugs, 2001
- Differential regulation of SAP8 and SAPS, which encode two new members of the secreted aspartic proteinase family in Candida albicansMicrobiology, 1998
- Activity of MK-0991 (l-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp.Diagnostic Microbiology and Infectious Disease, 1998
- Overexpression of Candida albicans secretory aspartyl proteinase 2 and its expression in Saccharomyces cerevisiae do not augment virulence in miceMicrobiology, 1998
- Potential new antifungal agentsCurrent Opinion in Infectious Diseases, 1997
- Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicansMolecular Microbiology, 1994
- ANTIBIOTICS THAT INHIBIT FUNGAL CELL WALL DEVELOPMENTAnnual Review of Microbiology, 1994
- Pneumocandin antifungal lipopeptides. The phenolic hydroxyl is required for 1,3-β-glucan synthesis inhibition.Bioorganic & Medicinal Chemistry Letters, 1993
- Experimental oral candidosis in the mouse: microbiologic and histologic aspectsJournal of Oral Pathology & Medicine, 1990